BioHarvest Sciences Inc. Common Stock Cash Flow-to-Debt Ratio
BioHarvest Sciences Inc. Common Stock cash flow-to-debt ratio. BioHarvest Sciences Inc. Common Stock (BHST) has a Cash Flow-to-Debt Ratio of -0.11x as of June 2026, meaning its operating cash flow of $-2.77 Million could theoretically repay 0% of its total liabilities ($24.80 Million) in one year. Check BioHarvest Sciences Inc. Common Stock cash earnings quality to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of BioHarvest Sciences Inc. Common Stock (2015–2025)
Cash flow-to-debt ratio of BioHarvest Sciences Inc. Common Stock from 2015 to 2025. Historical debt coverage capacity for BioHarvest Sciences Inc. Common Stock across 10 annual periods. Check BioHarvest Sciences Inc. Common Stock investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
BioHarvest Sciences Inc. Common Stock Cash Flow-to-Debt Ratio by Year (2015–2025)
BioHarvest Sciences Inc. Common Stock cash flow-to-debt ratio by year from 2015 to 2025. Year-by-year debt coverage analysis for BioHarvest Sciences Inc. Common Stock. For the full cash flow conversion analysis, see BHST operating cash flow.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.33x | $-7.23 Million | $22.22 Million | ▼ -15.2% |
| 2024 | -0.28x | $-6.68 Million | $23.67 Million | ▲ +1.1% |
| 2023 | -0.29x | $-8.52 Million | $29.86 Million | ▲ +52.7% |
| 2022 | -0.60x | $-9.24 Million | $15.32 Million | ▲ +34.7% |
| 2021 | -0.92x | $-6.79 Million | $7.35 Million | ▼ -81.2% |
| 2020 | -0.51x | $-3.88 Million | $7.60 Million | ▼ -520.4% |
| 2019 | -0.08x | $-2.38 Million | $28.99 Million | ▼ -127.7% |
| 2017 | -0.04x | $-1.00K | $27.70K | ▲ +94.1% |
| 2016 | -0.62x | $-74.60K | $121.17K | ▲ +72.4% |
| 2015 | -2.23x | $-126.82K | $56.86K | — |